Neoadjuvant Treatment in Breast Cancer Clinical Trial
— NEOADJOfficial title:
Prospective and Retrospective Neoadjuvant Breast Cancer Database
The NEOADJ Database base contains data collected during the regular clinical patient
management (sociodemographic, clinical, pathological, radiological, biological, disease
evolution...). This database allows easy access to information in a centralized and
structured way.
This cohort is used to gather insights for research purposes. All data collected come from
medical files of patients managed at Centre Georges Francois Leclerc, Dijon, France.
| Status | Recruiting |
| Enrollment | 2000 |
| Est. completion date | September 2024 |
| Est. primary completion date | September 2024 |
| Accepts healthy volunteers | No |
| Gender | Female |
| Age group | 18 Years and older |
| Eligibility |
Inclusion Criteria: - Women followed for breast cancer in Georges Francois Leclerc Center - Neoadjuvant chemotherapy - Age >= 18 Exclusion Criteria: - Males - Metastatic breast cancer |
| Country | Name | City | State |
|---|---|---|---|
| France | Methodology, Biostatistics and Data Management Unit | Dijon |
| Lead Sponsor | Collaborator |
|---|---|
| Centre Georges Francois Leclerc |
France,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Patient survival | Overall survival and evolution over years | 5 years | |
| Secondary | Collection of patient and treatment characteristics | Collection of patient and treatment characteristics over years, to set up prospective and retrospective studies | 5 years |